TScan Therapeutics, Inc.
TCRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$127 | -$89 | -$66 | -$49 |
| Dep. & Amort. | $4 | $5 | $5 | $3 |
| Deferred Tax | $0 | $0 | $0 | -$9 |
| Stock-Based Comp. | $10 | $5 | $5 | $3 |
| Change in WC | $5 | $18 | -$10 | -$6 |
| Other Non-Cash | -$2 | -$0 | $0 | $9 |
| Operating Cash Flow | -$111 | -$61 | -$67 | -$49 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$4 | -$3 | -$4 | -$10 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$241 | -$78 | $0 | $0 |
| Inv. Sales/Matur. | $193 | $20 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$53 | -$61 | -$4 | -$10 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $15 | $0 | $29 | $0 |
| Stock Issued | $33 | $42 | $0 | $90 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $160 | $93 | -$0 | $100 |
| Financing Cash Flow | $209 | $135 | $29 | $190 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $45 | $13 | -$41 | $131 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $138 | $125 | $166 | $35 |
| End Cash | $184 | $138 | $125 | $166 |
| Free Cash Flow | -$115 | -$65 | -$71 | -$59 |